DCM
CCXI

Delpha Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Delpha Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-392
Closed -$2K – 1395
2017
Q4 		$2K Buy
+392
New +$2.69K ﹤0.01% 1519

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Delpha Capital Management's CCXI Position: Q1 2018 in Review

Delpha Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2018, closing a stake of 392 shares — an estimated $2K sold.

Delpha Capital Management first reported a position in CCXI in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 100 funds tracked by Wall St. Rank hold CCXI as of Q1 2018.

  • Delpha Capital Management reported no remaining ChemoCentryx, Inc. position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 392 ChemoCentryx, Inc. shares in Q1 2018, an estimated $2K.
  • Delpha Capital Management first reported a position in ChemoCentryx, Inc. in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's ChemoCentryx, Inc. position peaked at $2K in Q4 2017.
  • 100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.